Migraine associated with early onset postpartum depression in women with major depressive disorder.
Katherine Gordon-SmithPaul RidleyAmy PerryNicholas CraddockIan R JonesLisa A JonesPublished in: Archives of women's mental health (2021)
Major depressive disorder (MDD) and migraine are both more common among women than men. Women's reproductive years are associated with increased susceptibility to recurrence of both conditions, suggesting a potential role of sex hormones in aetiology. We examined associations between comorbid migraine and clinical features of MDD in women, including relationships with lifetime reproductive events such as childbirth. Lifetime clinical characteristics and reproductive events in a well-characterised sample of 222 UK women with recurrent MDD, with (n = 98) and without (n = 124) migraine were compared. Women had all been recruited as part of a UK-based ongoing programme of research into the genetic and non-genetic determinants of mood disorders. Multivariate analysis showed a specific association between the lifetime presence of migraine and postpartum depression (PPD) within 6 weeks of delivery (OR = 2.555; 95% CI: 1.037-6.295, p = 0.041). This association did not extend to a broader definition of PPD with onset up to 6 months postpartum. All other factors included in the analysis were not significantly associated with the presence of migraine: family history of depression, younger age at depression onset, history of suicide attempt and severe premenstrual syndrome symptoms. The finding that women with MDD and comorbid migraine may be particularly sensitive to hormonal changes early in the postpartum period leads to aetiological hypotheses and suggests this group may be useful for future studies attempting to characterise PPD and MDD phenotypes. The refinement of such phenotypes has implications for individualising risk and treatment and for future biological and genetic studies.
Keyphrases
- major depressive disorder
- bipolar disorder
- polycystic ovary syndrome
- early onset
- sleep quality
- depressive symptoms
- pregnancy outcomes
- genome wide
- copy number
- insulin resistance
- breast cancer risk
- adipose tissue
- cervical cancer screening
- metabolic syndrome
- gene expression
- study protocol
- risk assessment
- clinical trial
- randomized controlled trial
- case control
- pregnant women
- drug induced
- smoking cessation
- skeletal muscle
- replacement therapy
- preterm birth
- climate change
- gestational age